Innate Pharma (IPHA) Liabilities and Shareholders Equity (2017 - 2026)
Innate Pharma (IPHA) reported Liabilities and Shareholders Equity of $40.36 million for the quarter ended Jun 30, 2026, down 61.6% from $105.2 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Liabilities and Shareholders Equity of $70.86 million, down 41.0% from the prior year.
- Liabilities and Shareholders Equity has declined for seven consecutive years, with a five-year compound annual growth rate of -27.4% (years ended Dec 2020 to Dec 2025).
- By year, Liabilities and Shareholders Equity came in at $120.2 million in the year ended Dec 31, 2024 (-39.7%), $199.24 million in the year ended Dec 31, 2023 (-9.1%), $219.08 million in the year ended Dec 31, 2022 (-28.4%) and $306.01 million in the year ended Dec 31, 2021 (-12.8%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Liabilities and Shareholders Equity in data going back to the quarter ended Dec 31, 2017.
- Across the past five years, year-over-year decline in Liabilities and Shareholders Equity ran from 7.3% in the quarter ended Dec 31, 2023 to 61.6% in the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Innate Pharma | 143.35 Mn | -63.85 Mn | - | 39.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.66 Mn |
| Dec 31, 2025 | 73.68 Mn |
| Jun 30, 2025 | 108.99 Mn |
| Dec 31, 2024 | 115.57 Mn |
| Jun 30, 2024 | 162.23 Mn |
| Dec 31, 2023 | 193.90 Mn |
| Jun 30, 2023 | 216.33 Mn |
| Dec 31, 2022 | 212.46 Mn |
| Jun 30, 2022 | 292.95 Mn |
| Dec 31, 2021 | 302.94 Mn |
| Jun 30, 2021 | 316.85 Mn |
| Dec 31, 2020 | 378.13 Mn |
| Jun 30, 2020 | 374.61 Mn |
| Dec 31, 2019 | 449.62 Mn |
| Dec 31, 2018 | 516.19 Mn |
| Dec 31, 2017 | 304.54 Mn |
API Access
Innate Pharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();